The treatment of prolonged erection after intracavernous injection of a vasoactive drug
Henriet, J.P.
Phlebologie 43(4): 587-591
1990
ISSN/ISBN: 0031-8280 PMID: 2093909 Document Number: 363325
The intracavernous injection of a vaso-active drug may induce an erection lasting for over 3 hours. The physician must carry out a simple procedure: an evacuatory puncture, which results in immediate detumescence of the penis and spares the patient any complications.
Document emailed within 1 workday
Related Documents
Ferrière, J.M.; Gaston, R.; Piechaud, T.; Le Guillou, M. 1988: Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances Annales d'Urologie 22(1): 57-59Adaikan, P.G.; Ratnam, S.S. 1988: Pharmacological consideration of intracavernous drug injection in the treatment of impotence Acta Urologica Belgica 56(2): 149-153
Sparwasser, C.; Treiber, U.; Bahren, W.; Gall, H.; Holzki, G.; Scherb, W. 1991: Postoperative erectile dysfunction; evaluation and treatment with intracavernous vasoactive injections Progress in Clinical and Biological Research 370: 349-354
Bondil, P. 1994: Management of drug-induced prolonged erection Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 4(5 Suppl 2: 84-88
Xing, J-ping.; Cui, X-feng.; Sun, J-hua.; Li, Q.; Liu, J.; Qiu, S-dong. 2005: Intracavernous pressure responses induced by electrical stimulation of penile dorsal nerves and intracavernosal drug injection in rats Zhonghua Nan Ke Xue 11(4): 281-3 287
Kattan, S.A. 2002: The acceptance and satisfaction of Saudi males to vasoactive autoinjection intracavernous therapy, external negative pressure device and penile prosthesis in the treatment of erectile dysfunction Annals of Saudi Medicine 22(3-4): 149-152
Pagliarulo, A.; Ludovico, G.M.; Cirillo-Marucco, E.; Corvasce, A.; Pagliarulo, G. 1996: Compliance to longterm vasoactive intracavernous therapy International Journal of Impotence Research 8(2): 63-64
Sønksen, J.O.; Hansen, E.F.; Biering-Sørensen, F.; Colstrup, H. 1990: Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries Ugeskrift for Laeger 152(41): 3006-3009
Suh, J.K.; Mun, K.H.; Cho, C.K.; Shin, H.C.; Kim, Y.S.; Park, T.C. 1995: Effect of vasoactive intestinal peptide and acetylcholine on penile erection in the rat in vivo International Journal of Impotence Research 7(2): 111-118
De Boer, B.J.; Lycklama a Nijeholt, A.A.; Kleinjans, H.A. 2001: Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology Nederlands Tijdschrift Voor Geneeskunde 145(16): 783-787
Lin, S.N.; Liu, R.S.; Chou, Y.H.; Chang, J.M.; Yeh, S.H.; Chang, L.S. 1988: Diagnosis of impotence by intracavernous injection of papaverine Zhonghua Yi Xue Za Zhi 41(2): 123-126
Takimoto, Y.; Kawazoe, K.; Hosokawa, H.; Hamada, T.; Ono, M.; Aoki, Y.; Yasuoka, S. 1989: Investigation of intracavernous injection of papaverine for erectile impotence Hinyokika Kiyo. Acta Urologica Japonica 35(1): 71-76
Marín Lafuente, J.C.; Sańchez Moreno Horencia, M.; Puy Figuero Echeverría, M.; Llarena Ibarguren, R.; Pertusa Peña, C. 1990: Intracavernous injection of prostaglandin E1 as a diagnostic test in erectile dysfunction Archivos Espanoles de Urologia 43(6): 661-663
Trigo-Rocha, F.; Donatucci, C.F.; Hsu, G.L.; Nunes, L.; Lue, T.F.; Tanagho, E.A. 1995: The effect of intracavernous injection of potassium channel openers in monkeys and dogs International Journal of Impotence Research 7(1): 41-48
Aguirre-Contreras, J.A.; Meza y Gutiérrez, E. 1977: Treatment of blood circulation disorders with a hemoactive-vasoactive drug La Prensa Medica Mexicana 42(11-12): 509-515
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Jackson, L.A.; Bailey, D.L.; Fraser, J.R.; Johnson, J.K.; Currie, A.; Babineau, D.D. 2002: Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia. An exploratory look at community and interpersonal influences Canadian Journal of Public Health 93(3): 219-222
Latkin, C.; Srikrishnan, A.K.; Yang, C.; Johnson, S.; Solomon, S.S.; Kumar, S.; Celentano, D.D.; Solomon, S. 2010: The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India Drug and Alcohol Dependence 110(3): 221-227
Navratil, H.; Costa, P.; Louis, J.F.; Andro, M.C.; Saur, P. 1995: Effectiveness of and tolerance to intracavernous injection of moxisylyte in patients with erectile dysfunction: effect/dose relationship versus placebo Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(5): 690-696
Zaller, N.; Mazhnaya, A.; Larney, S.; Islam, Z.; Shost, A.; Prokhorova, T.; Rybak, N.; Flanigan, T. 2015: Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care International Journal on Drug Policy 26(1): 37-42